Premium
Japanese Old Stories Cognitive Scale: a screening test to detect cognitive disease and prompt visiting a memory clinic
Author(s) -
Honjo Yasuyuki,
Takechi Hajime
Publication year - 2019
Publication title -
psychogeriatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.647
H-Index - 32
eISSN - 1479-8301
pISSN - 1346-3500
DOI - 10.1111/psyg.12398
Subject(s) - memory clinic , dementia , cognition , outpatient clinic , referral , cognitive test , test (biology) , medicine , psychiatry , screening test , psychology , disease , pediatrics , cognitive impairment , clinical psychology , family medicine , paleontology , pathology , biology
Background Early detection and diagnosis is critical in enhancing treatment outcomes for those with cognitive disease. However, most Japanese patients are averse to visiting mental health clinics or taking cognitive screening examinations. A new simple screening test is needed that is acceptable to patients and encourages them to visit a memory clinic if indicated. Methods We developed a brief screening examination, consisting of four common Japanese old stories, for detection of cognitive disease. A total of 311 patients at three outpatient memory clinics completed the screening test, responding to a 10‐question, fill‐in‐the‐blanks assessment. Questions were read aloud to patients with visual impairment, and we transcribed the spoken responses of patients who were physically incapable of writing. The Hasegawa Dementia Scale‐Revised (HDS‐R) and Mini‐Mental State Examination (MMSE) were administered at the same time. Results Using the developed Japanese Old Stories Cognitive Scale (JOSS), we found significant differences between dementia and control or mild cognitive impairment (MCI) groups. The JOSS was less affected by education level than the HDS‐R or MMSE, possibly because Japanese old stories are usually learned from family members during preschool years. The JOSS may be able to detect remote memory disturbance in addition to other cognitive dysfunctions. Conclusions Most patients with AD, even in advanced stages, are averse to visiting a memory clinic because it can be difficult to accept any resulting diagnosis of cognitive disease. JOSS is a quick and simple screening tool to gather evidence of cognitive dysfunction and prompt a referral to a memory clinic. Patients with cognitive disease found the JOSS acceptable, and its high specificity could be useful in encouraging patients to visit already‐crowded memory clinics for formal diagnosis and intervention.